A groundbreaking treatment for type 2 diabetes has emerged, offering hope to millions of patients worldwide. This innovative ...

Early morning hyperglycemia is sometimes called the “dawn phenomenon.” Left untreated, it can drive poorer outcomes. How can ...

Revolutionary glucose-responsive insulin NNC2215 offers hope for diabetics, managing blood sugar levels without hypoglycemia ...

Marlaina Goedel, diagnosed at age 5, said she is no longer on insulin. For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming.” ...

Hybrid closed-loop insulin therapy prevents low night-time blood glucose levels among breastfeeding mothers with type 1 ...

IN A GROUNDBREAKING medical achievement, a 25-year-old woman with Type 1 diabetes (T1D) in China has successfully undergone a ...

“These results support the continued investigation of intranasal insulin and empagliflozin combination therapy for AD,” they ...

As per a report by Livescience, the team extracted fat cells from a woman with type 1 diabetes and chemically reverted these ...

Insulcloud today announced its strategic expansion into the U.S. following FDA clearance for its Insulclock CAP smart device.

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

Fat-derived cellular concentrate is a promising treatment for people with uncontrolled diabetes who are dependent on insulin.